Alu Overexpression Leads to an Increased Double-Stranded RNA Signature in Dermatomyositis
Rayan Najjar1, Andrew Mammen2, Tomas Mustelin1
1University of Washington, Seattle.
Arthritis & Rheumatology (Hoboken, N.J.)
|July 22, 2025
Summary
Overexpressed Alu elements in dermatomyositis muscle tissue form double-stranded RNA (dsRNA), triggering interferon production. This suggests a novel mechanism in autoimmune disease pathogenesis involving the non-coding genome.
Area of Science:
- Genomics
- Immunology
- Molecular Biology
Background:
- Dermatomyositis is an autoimmune disease with a high interferon signature of unknown cause.
- The non-coding genome, including abundant Alu elements, plays a potential role in disease pathogenesis.
- Alu elements can form double-stranded RNA (dsRNA), activating MDA5 and leading to interferon production.
Purpose of the Study:
- To investigate the role of Alu elements and their expression in dermatomyositis.
- To explore the relationship between Alu expression, RNA editing, and interferon signatures in dermatomyositis.
Main Methods:
- Analyzed muscle biopsy RNA sequencing data from dermatomyositis patients and healthy controls.
- Quantified expression of short interspersed elements, including Alus, and A-to-I RNA editing.
- Correlated Alu expression and editing patterns with interferon-stimulated genes and disease activity markers.
Main Results:
- Dermatomyositis muscle tissue showed significantly elevated global and unique Alu element expression compared to controls.
- Overexpressed Alus, particularly inverted repeat types, were found outside of coding genes and correlated with disease activity.
- A unique expansion of Alu A-to-I editing was observed, indicating increased dsRNA, with edited Alus clustering on chromosome 19.
Conclusions:
- Hypothesize that overexpressed Alus in dermatomyositis generate endogenous dsRNA that overwhelms RNA editing capacity.
- This dsRNA triggers innate immune sensors, leading to the characteristic interferon signature in dermatomyositis.
- Suggests a novel pathogenic mechanism driven by non-coding repetitive elements in autoimmune disease.


